Semaglutide has recently garnered considerable attention as a medication. This drug, initially developed for the treatment of diabetes, has shown remarkable results in weight loss, making it a dual-purpose treatment for individuals struggling with both conditions.
This article breaks down the intricacies of semaglutide, exploring how it works, its benefits, potential side effects, and its role in treating diabetes and obesity.
Understanding Semaglutide
Semaglutide marks a significant advancement in healthcare, with solid evidence backing its effectiveness.
What Is Semaglutide Made Of?
Semaglutide is a lab-made version of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). It’s made up of 31 amino acids, similar to the natural hormone, but with key modifications.
These modifications include:
- Substitution of a specific amino acid: This replacement helps semaglutide resist breakdown by the enzyme dipeptidyl peptidase-4 (DPP-4), allowing it to remain active in the body for an extended period.
- Attachment of an acid chain: This attachment helps semaglutide stay active for about a week, reducing the need for frequent dosing.
What Is Semaglutide Used For?
Semaglutide is mainly used for managing type 2 diabetes and obesity. Beyond diabetes and weight management, semaglutide has also shown potential cardiovascular benefits.
In a recent study, researchers found that semaglutide was better than a placebo (a pill with no active ingredient) at:
- Lowering the risk of dying from heart-related issues.
- Reducing the chance of having a heart attack.
- Decreasing the likelihood of experiencing a stroke.
These results were observed over an average period of about 40 months.
How Does Semaglutide Work?
Semaglutide works by binding to the body’s GLP-1 receptors, which trigger a series of physiological responses, including:
1. Stimulation of Insulin Secretion
When blood sugar levels rise after eating, semaglutide prompts the pancreas to secrete insulin, the hormone that plays a key role in reducing blood glucose levels. This process is glucose-dependent, meaning that insulin is only released when blood sugar levels are elevated, thereby reducing the risk of hypoglycemia (low blood sugar).
2. Inhibition of Glucagon Release
Semaglutide suppresses the release of glucagon, a hormone that increases blood glucose levels by facilitating the release of glucose stored in the liver. By inhibiting glucagon, semaglutide helps to prevent blood sugar spikes, contributing to better glycemic control.
3. Slowing Gastric Emptying
Another key action of semaglutide is its ability to slow down the rate at which food leaves the stomach. This prolongs the feeling of fullness after eating, reducing overall food intake and supporting weight loss efforts.
4. Appetite Suppression
According to a 2017 study, semaglutide acts on the brain’s appetite control centers, reducing hunger and cravings. This effect is particularly beneficial for individuals with obesity, as it helps them achieve and maintain significant weight loss.
How Fast Does Semaglutide Work?
Clinical trials have shown that significant reductions in HbA1c (a measure of sustained blood glucose levels) typically become evident after 12 weeks of continuous treatment. For weight loss, early signs begin within the first few weeks, but significant weight reduction usually occurs after 20 weeks of therapy.
Semaglutide for Weight Loss
In a landmark study known as the STEP (Semaglutide Treatment Effect in People with Obesity) trial, participants who received semaglutide experienced an average weight loss of 10% to 17% from their baseline over 68 weeks. Additionally, over 80% of participants experienced at least a 5% reduction in weight.
In addition to its potent weight loss effects, semaglutide offers other health benefits that make it a valuable tool in managing obesity:
1. Improved Cardiovascular Health
A large international study (SELECT Trial) tested semaglutide’s effectiveness and safety in improving heart health. In this study, more than 17,600 participants were randomly grouped to receive either semaglutide or a placebo, along with standard medical treatment and advice on healthy living. The results showed that semaglutide significantly lowered the risk of major cardiovascular events by 1.5%.
2. Enhanced Quality of Life
Semaglutide also improved physical functioning, as measured by two specific tools:
-
SF-36 (Short Form-36 Health Survey)
The SF-36 is a commonly utilized questionnaire that assesses health-related quality of life. It consists of 36 questions that cover eight different health domains:
- Physical Functioning
- Bodily Pain
- General Health Perceptions
- Physical Role Limitations
- Emotional Role Limitations
- Social Functioning
- Vitality (Energy/Fatigue)
- Mental Health
The SF-36 provides a comprehensive overview of a person’s overall health status and how it affects their daily life.
-
IWQOL-Lite-CT (Impact of Weight on Quality of Life-Lite Clinical Trials Version)
The IWQOL-Lite-CT measures the impact of weight on quality of life. It focuses on five key areas:
- Physical Function
- Self-Esteem
- Sexual Life
- Public Distress
- Work.
The “CT” version is adapted for use in clinical trials, making it a more precise tool for assessing how weight-related issues affect the quality of life, especially in studies involving weight-loss interventions like semaglutide.
Semaglutide was statistically proven to be better than the placebo across all measures tested in this study.
3. Reduction in Obesity-Related Conditions
Significant weight loss can help alleviate or even resolve obesity-related conditions such as sleep apnea, fatty liver disease, and joint pain. For many individuals, the use of semaglutide represents a transformative approach to managing their health and well-being.
Semaglutide for Diabetes Management
The SUSTAIN and PIONEER trials assessed how effective semaglutide is compared to other treatments in lowering HbA1c levels, a critical indicator of blood sugar control in type 2 diabetes.
Semaglutide consistently achieved more significant HbA1c reductions, ranging from 1.5% to 2.0% in the SUSTAIN trials and 0.5% to nearly 1.8% in the PIONEER trials, making it a superior choice for managing blood sugar.
Administration and Dosage of Semaglutide
The administration of semaglutide varies depending on the formulation and the condition being treated.
Ozempic
For type 2 diabetes management, Ozempic is typically administered as a once-weekly injection. The starting dose is usually 0.25 mg weekly, which can be raised to 0.5 mg or 1 mg based on the patient’s response and tolerance.
Related: A Step-by-Step Guide on How to Get Ozempic in 2024 and Ozempic Dosing Schedule Explained
Wegovy
For chronic weight management, Wegovy is also administered as a once-weekly injection. The dosing regimen typically starts at 0.25 mg per week, gradually increasing to 2.4 mg per week over several months to minimize side effects and improve tolerance.
Rybelsus
Rybelsus is an oral formulation of semaglutide used for type 2 diabetes. It is usually taken once daily, starting at a dose of 3 mg, which can be increased to 7 mg or 14 mg depending on the patient’s needs and response.
Semaglutide Side Effects and Risks
While semaglutide is highly effective for weight loss and diabetes management, it is not without potential side effects. Most side effects are mild and generally decrease over time as the body adapts to the medication.
Common Side Effects
- Nausea: Nausea is the most reported side effect of semaglutide, particularly during the initial weeks of treatment. To minimize this, start with a low dose and gradually increase it.
- Vomiting and Diarrhea: Some patients may experience gastrointestinal symptoms such as vomiting and diarrhea. Maintaining hydration and consuming smaller, more frequent meals can help manage these symptoms.
- Constipation: Constipation is another common side effect. Increasing dietary fiber and fluid intake can alleviate this issue.
Serious Side Effects
- Pancreatitis: Although rare, there is a risk of developing pancreatitis (inflammation of the pancreas) with semaglutide. Symptoms include intense pain in the abdominal area, nausea, and vomiting.
- Kidney Problems: Semaglutide can cause dehydration, which may worsen kidney function in some individuals.
- Thyroid Tumors: Animal studies have linked semaglutide to a higher risk of thyroid tumors. While this effect hasn’t been seen in humans, individuals with a history of thyroid cancer should consult their physician to discuss potential risks.
Other Potential Side Effects
1. Can Semaglutide Make You Tired?
Yes, semaglutide can cause fatigue. Some users report feeling more tired than usual while taking this medication.
2. Can Semaglutide Cause Hair Loss?
In clinical trials for Wegovy (semaglutide), hair loss (alopecia) was observed in 3% of adults taking Wegovy and 4% in children aged 12 and older.
3. Can Semaglutide Cause Headaches?
Yes, headaches can occur as a side effect of semaglutide. These may happen as the body adjusts to the medication.
4. Can Semaglutide Cause Depression or Anxiety?
NPR conducted an analysis of the FDA’s adverse event reporting system (FAERS) and found that the agency received 489 reports of patients experiencing anxiety, depression, or suicidal thoughts while using semaglutide medications like Ozempic, Wegovy, and Rybelsus. Among these cases, 96 involved patients reporting suicidal thoughts.
5. Can Semaglutide Affect Your Period?
Semaglutide itself does not typically affect menstrual cycles, but weight loss from the medication might cause changes in menstrual regularity.
6. Can Semaglutide Cause High Blood Pressure?
Semaglutide is not known to cause high blood pressure. In some cases, it may even help lower blood pressure in people with diabetes.
Cost of Semaglutide
Semaglutide costs vary based on insurance coverage, location, and whether it’s purchased as a brand-name or compounded drug.
1. How Much Is Semaglutide Without Insurance and With Insurance?
Without insurance, semaglutide can cost between $800 and $1,200 per month, depending on the dosage and pharmacy. With insurance, the cost varies depending on the plan. Patients may pay a copay ranging from $25 to $150 per month. It’s best to check with your insurance provider for exact costs.
Related: Is Ozempic Covered by Insurance?
2. How Much Is Semaglutide for Weight Loss?
Wegovy typically costs between $1,300 and $1,600 per month without insurance.
3. How Much Is Semaglutide Injection?
Semaglutide injections, like Ozempic or Wegovy, generally cost between $800 and $1,600 per month without insurance.
4. How Much Is Semaglutide in Mexico?
Semaglutide can cost between $400 and $600 for a month’s supply in Mexico.
5. How Much Is Semaglutide in Canada?
Through Pharma Giant, an online Canadian pharmacy partner that ships to the US, semaglutide prices are as follows:
Customers can also take advantage of extra discounts and special offers when ordering larger quantities. New customers can use the coupon code PGSAVE10 for a 10% discount on their first order.
Pharma Giant promises expedited delivery, with medications typically arriving within 3-5 business days. Strict measures are taken to package temperature-sensitive medications securely.
6. How Much Is Semaglutide Compound?
Compounded semaglutide may cost between $200 and $600 monthly.
Final Thoughts
Semaglutide is a groundbreaking medication that has transformed the strategy for managing type 2 diabetes and obesity. Patients considering semaglutide should discuss the potential risks and benefits with their physician to determine if it is the right choice. With proper medical guidance, semaglutide can be an invaluable part of a comprehensive strategy for managing diabetes and achieving weight loss.
Related Articles
Frequently Asked Questions
Sources
Blundell, J., Finlayson, G., Axelsen, M., Flint, A., Gibbons, C., Kvist, T., & Hjerpsted, J. B. (2017). Effects of once?weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obesity and Metabolism, 19(9), 1242–1251. https://doi.org/10.1111/dom.12932
Nauck, M. A., Petrie, J. R., Sesti, G., Mannucci, E., Courrèges, J., Lindegaard, M. L., Jensen, C. B., & Atkin, S. L. (2015). A Phase 2, randomized, Dose-Finding study of the novel Once-Weekly Human GLP-1 analog, semaglutide, compared with Placebo and Open-Label liraglutide in patients with type 2 diabetes. Diabetes Care, 39(2), 231–241. https://doi.org/10.2337/dc15-0165
Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., Deanfield, J., Emerson, S. S., Esbjerg, S., Hardt-Lindberg, S., Hovingh, G. K., Kahn, S. E., Kushner, R. F., Lingvay, I., Oral, T. K., Michelsen, M. M., Plutzky, J., Tornøe, C. W., & Ryan, D. H. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine, 389(24), 2221–2232. https://doi.org/10.1056/nejmoa2307563
Bergmann, N. C., Davies, M. J., Lingvay, I., & Knop, F. K. (2022). Semaglutide for the treatment of overweight and obesity: A review. Diabetes Obesity and Metabolism, 25(1), 18–35. https://doi.org/10.1111/dom.14863
Le, K. D. R., Le, K., & Foo, F. (2024). The impact of glucagon-like peptide 1 receptor agonists on Obstructive sleep apnoea: a scoping review. Pharmacy, 12(1), 11. https://doi.org/10.3390/pharmacy12010011
Zhu, K., Kakkar, R., Chahal, D., Yoshida, E. M., & Hussaini, T. (2023). Efficacy and safety of semaglutide in non-alcoholic fatty liver disease. World Journal of Gastroenterology, 29(37), 5327–5338. https://doi.org/10.3748/wjg.v29.i37.5327
Baser, O., Isenman, L., Baser, S., & Samayoa, G. (2024). Impact of semaglutide on osteoarthritis risk in patients with obesity: A retrospective cohort study. Obesity Science & Practice, 10(3). https://doi.org/10.1002/osp4.762
Mahapatra, M. K., Karuppasamy, M., & Sahoo, B. M. (2022). Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes. Reviews in Endocrine and Metabolic Disorders, 23(3), 521–539. https://doi.org/10.1007/s11154-021-09699-1
